Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Gastroenterology & Hepatology|October 18, 2016
Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease scoreXiaoshu Li, Fangyuan Gao, Huimin Liu, et al.
NPJ Precision Oncology|May 5, 2021
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancerXi Jiao, Xin Wei, Shuang Li, et al.
Journal of Cancer|May 16, 2018
Quality Control of Next-generation Sequencing-based <i>In vitro</i> Diagnostic Test for Onco-relevant Mutations Using Multiplex Reference Materials in PlasmaDonglai Liu, Haiwei Zhou, Dawei Shi, et al.
NPJ Vaccines|June 18, 2026
Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinomaHenghui Zhang, Hao Liang, Tingting Dai, et al.
Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.
Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 14, 2020
The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinomaHaibei Xin, Dandan Liang, Minfeng Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2020
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung AdenocarcinomaTao Jiang, Zhaoyuan Fang, Shijie Tang, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
JAMA Network Open|July 25, 2019
Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract CancerZhihao Lu, Jianling Zou, Ying Hu, et al.
Pageof 13